Lysogene raises $25M in Paris IPO; Chan Zuckerberg Biohub starts handing out $50M
• The gene therapy company Lysogene has raised $25 million from an IPO on Euronext Paris designed to fund its R&D work. “This IPO …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
